ENTITY

Juno Therapeutics (JUNO US)

Analysis

Health Care • United States

Juno Therapeutics Inc. operates as a clinical-stage biotechnology company. The Company focuses on developing immunotherapies for cancer and other research services.

Refresh

No presentations found

We’ll display presentations we find for Juno Therapeutics here

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00